The potent stimulants of abuse as methamphetamine (METH) and cocaine (COC) are highly addictive compounds and encourage frequent persistent use. With chronic administration of these drugs, tolerance occurs which compounds and encourage frequent persistent use. With chronic administration of these drugs, tolerance occurs which leads to the use of particularly large quantities; this frequently leads to consequent escalation of psychotic, violent behavior, seizure initiation and other serious sequelae. The goal of this proposal is to elucidate and characterize those factors which influence the development of tolerance to METH and determine if changes and either metabolism of METH or CNS active transport are responsible for the phenomenon of tolerance. Our studies will examine the overall hypothesis: A tolerance-inducing pretreatment with METH causes a significant shift in the distribution patterns of this hypothesis: A tolerance-inducing pretreatment with METH causes a significant shift in the distribution patterns of this drug after subsequent METH challenges; however, cocaine pretreatment does not cause a similar phenomenon.
Three Specific Aims are proposed: (1) Identify the factors necessary for the induction of tolerance; (b) characterize disposition factors affecting the development of METH tolerance; and (c) investigate the possibility of cross-tolerance with other CNS stimulants, such as cocaine (COC).
In Specific Aim A, experiments are designed elements of METH are critical for induction and persistence of tolerance. Experiments for Specific Aim B will determine if METH pretreatment causes a shift in the active transport mechanisms for this stimulant. Finally, experiments for Specific Aim C will combine METH, COC or MDMA pretreatment, followed by challenge to determine the selectivity of the tolerance response. Our proposed studies will use a rat model for METH tolerance developed previously in the laboratory of Drs. Hanson and Gibb; moreover, mice genetically modified for expression of P-glycoproteins will also be used. The studies proposed will elucidate the nature of tolerance caused by METH, as well as identify the circumstance or type of METH exposures likely to cause this phenomenon. In addition, the results from this Project will elucidate the dynamic pharmacokinetic processes that determine the distribution of METH and related stimulants and help predict the consequences of various patterns of stimulant abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA013367-02
Application #
6599633
Study Section
Special Emphasis Panel (ZRG1)
Project Start
2002-06-01
Project End
2003-05-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
German, Christopher L; Gudheti, Manasa V; Fleckenstein, Annette E et al. (2017) Brain Slice Staining and Preparation for Three-Dimensional Super-Resolution Microscopy. Methods Mol Biol 1663:153-162
Baladi, Michelle G; Nielsen, Shannon M; McIntosh, J Michael et al. (2016) Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behav Pharmacol 27:422-30
Fricks-Gleason, Ashley N; German, Christopher L; Hoonakker, Amanda J et al. (2016) An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse 70:139-46
German, Christopher L; Baladi, Michelle G; McFadden, Lisa M et al. (2015) Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev 67:1005-24
Vieira-Brock, Paula L; McFadden, Lisa M; Nielsen, Shannon M et al. (2015) Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. J Pharmacol Exp Ther 355:463-72
Alburges, Mario E; Hoonakker, Amanda J; Cordova, Nathaniel M et al. (2015) Effect of low doses of methamphetamine on rat limbic-related neurotensin systems. Synapse 69:396-404
Vieira-Brock, Paula L; McFadden, Lisa M; Nielsen, Shannon M et al. (2015) Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits. Int J Neuropsychopharmacol 18:
McFadden, Lisa M; Vieira-Brock, Paula L; Hanson, Glen R et al. (2015) Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology 93:146-54
German, Christopher L; Fleckenstein, Annette E; Hanson, Glen R (2014) Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 97:2-8
Baladi, Michelle G; Nielsen, Shannon M; Umpierre, Anthony et al. (2014) Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats. Behav Pharmacol 25:758-65

Showing the most recent 10 out of 73 publications